Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

NCT02418247 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

556

Enrollment

OTHER_GOV

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: I131
DRUG: I123

Sponsor

National Cancer Center, Korea